PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (NASDAQ:AVII), announced that Patrick L. Iversen, Ph.D., AVI’s senior vice president of research and development, will present today at the inaugural 2007 Biodefense Research Conference, Bridging the Gap: Biodefense and Beyond, held Nov. 5–7 in Philadelphia. Dr. Iversen’s presentation will include updates on studies performed at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) evaluating the company’s NEUGENE® PLUS therapeutic antisense compounds in the treatment of nonhuman primates (NHP) exposed to Ebola virus or Marburg virus.
